AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 OCT 16 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Growth of a murine CT26 colon carcinoma was completely inhibited by immunization of the mice with a vaccine containing a heat shock protein and cells that produced granulocyte-macrophage colony stimulating factor (GM-CSF).
"Several studies have suggested a positive correlation between heat shock protein (hsp) expression and tumor immunogenicity," commented Xiang-Yang Wang and colleagues at the Roswell Park Cancer Institute in Buffalo, New York. "Independently, many studies have shown that hsp purified from tumors can be used as a tumor-specific vaccine."
The investigators incorporated the cDNA of heat shock protein 110 (hsp110) in murine CT26 colon carcinoma cells (CT26-hs110). In vitro, overexpression of the hsp did not affect tumor growth, but hsp-expressing tumors established in mice did grow significantly more slowly than wild-type CT26 tumors.
Vaccination of mice with inactivated CT26-hsp110 cells caused the proliferation of CD8+ (but not CD4+) tumor-specific T cells and natural killer (NK) cells and significantly inhibited the growth of wild-type CT26 tumors. Addition of GM-CSF-producing cells to the CT26-hsp110 cell vaccine completely prevented the growth of wild-type CT26 tumors.
"These observations demonstrate that ...
Source: HighBeam Research, Tumor cells overexpressing heat shock protein effectively inhibit...